The Securities and Exchange Commission on Wednesday said Theranos committed a “massive” financial fraud, “raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about the company’s technology, business, and financial performance.”
What the SEC did not get from either Theranos or company founder Elizabeth Holmes was an admission of guilt.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn